Home>Topics>>3 Biopharmaceuticals Weighed By Uncertainty
3 Biopharmaceuticals Weighed By Uncertainty
Healthcare Sector and Stocks Analysis from Seeking Alpha
Fri, 7 Dec 2012
By Cris Frangold : The American Journal of Preventive Medicine estimates that by 2030, 42 percent of U.S. adults could be obese, which would add approximately $550 billion to healthcare costs over that time frame. In 2012, the FDA approved two anti-obesity drugs: Arena Pharmaceuticals ( ARNA ) with ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.